| Steven F Schutzer, MD | |
|
85 Seymour St, Suite 607, Hartford, CT 06106-5501 | |
| (860) 549-3210 | |
| (860) 247-3803 |
| Full Name | Steven F Schutzer |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 46 Years |
| Location | 85 Seymour St, Hartford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265439368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 023828 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Orthopedics New England | 9335108547 | 21 |
News Archive
New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Fast food ads aimed at kids fail to de-emphasize toy premiums, making them deceptive by industry self-regulation standards. They also fail to emphasize healthy menu items, investigators at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found.
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.
› Verified 4 days ago
| Entity Name | Trinity Health Of New England Provider Network Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Fast food ads aimed at kids fail to de-emphasize toy premiums, making them deceptive by industry self-regulation standards. They also fail to emphasize healthy menu items, investigators at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found.
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.
› Verified 4 days ago
| Entity Name | Orthopedic Associates Of Hartford,pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972500304 PECOS PAC ID: 1850382409 Enrollment ID: O20040521000458 |
News Archive
New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Fast food ads aimed at kids fail to de-emphasize toy premiums, making them deceptive by industry self-regulation standards. They also fail to emphasize healthy menu items, investigators at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found.
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.
› Verified 4 days ago
| Entity Name | Advanced Orthopedics New England |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215086459 PECOS PAC ID: 9335108547 Enrollment ID: O20041005000030 |
News Archive
New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Fast food ads aimed at kids fail to de-emphasize toy premiums, making them deceptive by industry self-regulation standards. They also fail to emphasize healthy menu items, investigators at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found.
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Steven F Schutzer, MD 85 Seymour St, Suite 607, Hartford, CT 06106-5501 Ph: (860) 549-3210 | Steven F Schutzer, MD 85 Seymour St, Suite 607, Hartford, CT 06106-5501 Ph: (860) 549-3210 |
News Archive
New research reveals that, in the U.S., Black patients with lupus have a threefold higher risk of stroke and a 24-fold higher risk of ischemic heart disease.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.
Fast food ads aimed at kids fail to de-emphasize toy premiums, making them deceptive by industry self-regulation standards. They also fail to emphasize healthy menu items, investigators at Dartmouth-Hitchcock's Norris Cotton Cancer Center have found.
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery mechanism that could pave the way for implants that release a drug at a designated rate for months.
› Verified 4 days ago
Gerald J Becker, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 85 Seymour St, Suite 607, Hartford, CT 06106 Phone: 860-549-3210 Fax: 860-247-3803 | |
Jeffrey Jon Meter, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1000 Asylum Ave, Suite 4307, Hartford, CT 06105 Phone: 860-714-4085 | |
Dr. Peter R Barnett, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 85 Seymour St, Suite 607, Hartford, CT 06106 Phone: 860-549-3210 Fax: 860-247-3803 | |
Hanbing Zhou, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 31 Seymour Street, Suite 100, Hartford, CT 06106 Phone: 860-549-8261 Fax: 860-247-3803 | |
Heeren S Makanji, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 31 Seymour St Ste 100, Hartford, CT 06106 Phone: 860-549-3210 Fax: 860-244-1075 | |
Courtland G Lewis, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 85 Seymour St, Suite 607, Hartford, CT 06106 Phone: 860-549-8232 Fax: 860-247-3803 | |
Christopher Harry Judson, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 31 Seymour Street, Suite 100, Hartford, CT 06106 Phone: 860-549-3210 Fax: 860-247-3803 |